Bildkälla: Stockfoto

Egetis Therapeutics: Recommendation from the European Thyroid Association - Redeye

Redeye endorses today’s news that the ETA (“European Thyroid Association”) recommends Emcitate as a long-term treatment for MCT8 deficiency and we give a short comment.

Redeye endorses today’s news that the ETA (“European Thyroid Association”) recommends Emcitate as a long-term treatment for MCT8 deficiency and we give a short comment.
Börsvärldens nyhetsbrev
ANNONSER